InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-13 | Carson William H. | Director | Purchase | 8,000 | $5.78 | $46K | 78.4K | View ↗ | |
| 2026-04-10 | 2026-04-14 | Carson William H. | Director | Purchase | 8,000 | $6.20 | $50K | 70.4K | View ↗ | |
| 2026-03-10 | 2026-03-12 | Carson William H. | Director | Purchase | 8,000 | $5.67 | $45K | 62.4K | View ↗ | |
| 2026-03-02 | 2026-03-04 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sale | 5,820 | $5.43 | $32K | 123.6K | View ↗ | |
| 2026-03-02 | 2026-03-04 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sale | 4,339 | $5.42 | $24K | 182.6K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $184.7M+54.6% | $119.4M+5.0% | $113.8M+1.1% | $112.5M |
| General and administrative | $31.7M-8.4% | $34.6M+15.5% | $30.0M-9.5% | $33.1M |
| Total operating expenses | $216.4M+40.5% | $154.1M+7.2% | $143.7M-1.3% | $145.6M |
| Loss from operations | -$216.4M-40.5% | -$154.1M-7.2% | -$143.7M+1.3% | -$145.6M |
| Interest and other income, net | $9.7M-38.8% | $15.9M+67.3% | $9.5M+159.7% | $3.7M |
| Net loss | -$206.7M-49.6% | -$138.2M-3.0% | -$134.2M+5.4% | -$141.9M |
| Deemed dividend on modification of common stock warrants | -$1.9M | $0 | — | — |
| Net loss attributable to common stockholders | -$208.5M-50.9% | -$138.2M | — | — |
| Net loss per share, basic | -$1K-32.7% | -$1K+42.9% | -$2K+31.9% | -$3K |
| Net loss per share, diluted | -$1K-32.7% | -$1K+42.9% | -$2K+31.9% | -$3K |
| Weighted-average shares used in computing net loss per share, basic | $155.11B+12.9% | $137.40B+81.6% | $75.67B+38.4% | $54.67B |
| Weighted-average shares used in computing net loss per share, diluted | $155.11B+12.9% | $137.40B+81.6% | $75.67B+38.4% | $54.67B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference
Annexon, Inc. (ANNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS
Exploring 3 High Growth Tech Stocks In The US Market